Efficacy and Safety of Ravulizumab in IgAN: Week 50 Results from a Phase 2 Randomized Controlled Trial

Authors: James A. Tumlin, Richard A. Lafayette, Jonathan Barratt, Mai-Szu Wu, Sung Gyun Kim, Jessica Katharina Kaufeld, Shih-Han S. Huang, Eric Alamartine, Miguel angel Pérez valdivia, Kara Rice, Andreas Kateifides, Katherine Garlo, Dario Roccatello

Published: 2024-10-28

DOI: 10.1681/asn.2024r76pk0r1

Keywords: No keywords found.

Abstract:
No abstract found.

Source: